173 related articles for article (PubMed ID: 8706049)
1. Bacillus Calmette-Guérin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-gamma, which inhibits B16F10 melanoma cell growth in vitro.
Fujimoto T; O'Donnell MA; Szilvasi A; Yang H; Duda RB
Cancer Immunol Immunother; 1996 Jun; 42(5):280-4. PubMed ID: 8706049
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
3. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
4. Role of Th1-stimulating cytokines in bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells.
Luo Y; Yamada H; Evanoff DP; Chen X
Clin Exp Immunol; 2006 Oct; 146(1):181-8. PubMed ID: 16968412
[TBL] [Abstract][Full Text] [Related]
5. Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect.
Luo Y; Chen X; O'Donnell MA
Cytokine; 2003 Jan; 21(1):17-26. PubMed ID: 12668155
[TBL] [Abstract][Full Text] [Related]
6. IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy.
Luo Y; Chen X; Downs TM; DeWolf WC; O'Donnell MA
J Immunol; 1999 Feb; 162(4):2399-405. PubMed ID: 9973521
[TBL] [Abstract][Full Text] [Related]
7. Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro.
Liu W; O'Donnell MA; Chen X; Han R; Luo Y
Cancer Immunol Immunother; 2009 Oct; 58(10):1647-55. PubMed ID: 19214503
[TBL] [Abstract][Full Text] [Related]
8. Effects of bacillus Calmette-Guèrin and interferon alpha-2B on cytokine production in human bladder cancer cell lines.
Zhang Y; Khoo HE; Esuvaranathan K
J Urol; 1999 Mar; 161(3):977-83. PubMed ID: 10022737
[TBL] [Abstract][Full Text] [Related]
9. Recombinant BCG therapy suppresses melanoma tumor growth.
Duda RB; Yang H; Dooley DD; Abu-Jawdeh G
Ann Surg Oncol; 1995 Nov; 2(6):542-9. PubMed ID: 8591086
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes.
O'Donnell MA; Aldovini A; Duda RB; Yang H; Szilvasi A; Young RA; DeWolf WC
Infect Immun; 1994 Jun; 62(6):2508-14. PubMed ID: 8188376
[TBL] [Abstract][Full Text] [Related]
11. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.
Chang AE; Aruga A; Cameron MJ; Sondak VK; Normolle DP; Fox BA; Shu S
J Clin Oncol; 1997 Feb; 15(2):796-807. PubMed ID: 9053507
[TBL] [Abstract][Full Text] [Related]
12. Quadruple immunotherapy of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.
Steinberg RL; Nepple KG; Velaer KN; Thomas LJ; O'Donnell MA
Urol Oncol; 2017 Dec; 35(12):670.e7-670.e14. PubMed ID: 28801026
[TBL] [Abstract][Full Text] [Related]
13. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
[TBL] [Abstract][Full Text] [Related]
14. Bacillus Calmette-Guérin immunotherapy induces an efficient antitumor response to control murine melanoma depending on MyD88 signaling.
Borges VM; Marinho FV; Caldeira CVA; de Queiroz NMGP; Oliveira SC
Front Immunol; 2024; 15():1380069. PubMed ID: 38835781
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.
Sampson JH; Archer GE; Ashley DM; Fuchs HE; Hale LP; Dranoff G; Bigner DD
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10399-404. PubMed ID: 8816812
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-gamma.
Arnold J; de Boer EC; O'Donnell MA; Böhle A; Brandau S
J Immunother; 2004; 27(2):116-23. PubMed ID: 14770083
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent synergy of Th1-stimulating cytokines on bacille Calmette-Guérin-induced interferon-gamma production by human mononuclear cells.
Chen X; O'DONNELL MA; Luo Y
Clin Exp Immunol; 2007 Jul; 149(1):178-85. PubMed ID: 17517055
[TBL] [Abstract][Full Text] [Related]
18. Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guérin.
O'Donnell MA; Luo Y; Chen X; Szilvasi A; Hunter SE; Clinton SK
J Immunol; 1999 Oct; 163(8):4246-52. PubMed ID: 10510362
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-mediated antitumor effect of bacillus Calmette-Guérin on tumor cells in vitro.
Kurisu H; Matsuyama H; Ohmoto Y; Shimabukuro T; Naito K
Cancer Immunol Immunother; 1994 Oct; 39(4):249-53. PubMed ID: 7954527
[TBL] [Abstract][Full Text] [Related]
20. A novel recombinant Mycobacterium bovis bacillus Calmette-Guerin strain expressing human granulocyte macrophage colony-stimulating factor and Mycobacterium tuberculosis early secretory antigenic target 6 complex augments Th1 immunity.
Yang X; Bao L; Deng Y
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):511-8. PubMed ID: 21676888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
